Q1 2025 Holdings
Filed 2025-05-15 | 473 holdings | $367.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $99.0K | 44,007 | 0.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $99.0K | 2,953 | 0.0% |
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $99.0K | 9,353 | 0.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $99.9K | 22,153 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $100.6K | 10,818 | 0.0% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $100.8K | 47,307 | 0.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $101.4K | 72,957 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $101.7K | 5,953 | 0.0% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $101.9K | 13,455 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $104.3K | 6,368 | 0.0% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $106.5K | 37,225 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $106.5K | 3,891 | 0.0% |
| Cartesian Therapeutics Inc(RNAC) | COM NEW | 816212302 | $107.5K | 8,160 | 0.0% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $108.5K | 54,535 | 0.0% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $108.6K | 11,448 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $108.7K | 19,473 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $109.9K | 62,421 | 0.0% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $110.7K | 6,861 | 0.0% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $110.9K | 7,289 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $111.8K | 16,942 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $112.1K | 20,674 | 0.0% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $112.7K | 6,208 | 0.0% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $114.4K | 5,856 | 0.0% |
| Acelyrin Inc | COM | 00445A100 | $114.5K | 46,372 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $115.6K | 10,906 | 0.0% |
| American Assets TR Inc(AAT) | COM | 024013104 | $116.1K | 5,765 | 0.0% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $117.4K | 6,348 | 0.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $117.9K | 19,687 | 0.0% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $118.5K | 9,097 | 0.0% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $118.7K | 81,270 | 0.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $119.2K | 3,050 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $120.4K | 26,348 | 0.0% |
| Civitas Resources Inc(CIVI) | COM NEW | 17888H103 | $122.1K | 3,500 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $123.1K | 9,129 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $123.4K | 20,663 | 0.0% |
| Apple Hospitality REIT Inc(APLE) | COM NEW | 03784Y200 | $124.0K | 9,603 | 0.0% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $124.1K | 55,645 | 0.0% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $124.4K | 23,518 | 0.0% |
| Site Ctrs Corp(SITC) | COM | 82981J851 | $124.5K | 9,696 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $126.6K | 3,939 | 0.0% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $126.7K | 6,986 | 0.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $126.9K | 2,556 | 0.0% |
| Berry Corp(BRY) | COM | 08579X101 | $127.0K | 39,551 | 0.0% |
| Northern Oil & Gas Inc(NOG) | COM | 665531307 | $127.4K | 4,214 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $128.2K | 5,829 | 0.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $129.1K | 1,968 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $129.1K | 3,652 | 0.0% |
| California RES Corp(CRC) | COM STOCK | 13057Q305 | $130.4K | 2,965 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $131.0K | 13,434 | 0.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $131.4K | 3,270 | 0.0% |